Fred Alger Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Buy
270,115
+212,307
+367% +$11.5M 0.07% 127
2025
Q4
$2.67M Buy
57,808
+12,394
+27% +$554K 0.01% 296
2025
Q3
$1.64M Buy
45,414
+27,143
+149% +$899K 0.01% 335
2025
Q2
$594K Sell
18,271
-4,089
-18% -$134K ﹤0.01% 380
2025
Q1
$844K Sell
22,360
-500,647
-96% -$40M ﹤0.01% 336
2024
Q4
$42.8M Sell
523,007
-720,710
-58% -$71.6M 0.2% 77
2024
Q3
$142M Sell
1,243,717
-66,719
-5% -$6.01M 0.69% 30
2024
Q2
$99M Sell
1,310,436
-86,275
-6% -$5.87M 0.48% 45
2024
Q1
$95.4M Sell
1,396,711
-273,478
-16% -$18.9M 0.47% 44
2023
Q4
$105M Sell
1,670,189
-423,116
-20% -$22M 0.57% 44
2023
Q3
$107M Sell
2,093,305
-277,913
-12% -$13.7M 0.61% 38
2023
Q2
$118M Buy
2,371,218
+1,526,440
+181% +$72.4M 0.6% 37
2023
Q1
$31.7M Sell
844,778
-32,515
-4% -$1.38M 0.17% 137
2022
Q4
$42.1M Buy
+877,293
New +$34.4M 0.23% 127
2022
Q2
Sell
-9,677
Closed -$234K 538
2022
Q1
$234K Buy
+9,677
New +$211K ﹤0.01% 434

Other funds holding PCVX